Literature DB >> 31453628

Dominant Dystrophic Epidermolysis Bullosa Pruriginosa Responding to Naltrexone Treatment.

Kristine A U Pallesen1, Kim H Lindahl, Anette Bygum.   

Abstract

Entities:  

Keywords:  epidermolysis bullosa; naltrexone; epidermolysis bullosa pruriginosa

Mesh：

Substances：

Year:  2019        PMID： 31453628     DOI： 10.2340/00015555-3304

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  2 in total

Review 1.  Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa.

Authors:  Verena Wally; Manuela Reisenberger; Sophie Kitzmüller; Martin Laimer
Journal:  Orphanet J Rare Dis       Date:  2020-10-19       Impact factor: 4.123

2.  Misdiagnosed dystrophic epidermolysis bullosa pruriginosa: A case report.

Authors:  Zi Wang; Yi Lin; Xing-Wu Duan; Hai-Yan Hang; Xia Zhang; Ling-Ling Li
Journal:  World J Clin Cases       Date:  2021-05-06       Impact factor: 1.337
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.